Skip to content

A randomized ctontrolled study for Guhong injection in the treatment of microcoronary microvascular dysfunction

A randomized ctontrolled study for Guhong injection in the treatment of microcoronary microvascular dysfunction

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002310
Enrollment
Unknown
Registered
2019-04-30
Start date
2019-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary microvascular dysfunction

Interventions

Sponsors

The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine (Guangdong Provincial Hospital of Traditional Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Coronary angiography or coronary CT showed no unstable coronary atherosclerotic plaque or coronary artery stenosis = 50%, accompanied by patients with stable angina clinical symptoms. 2. Aged over 35 years and under 75 years, gender is not limited; 3. The patient agrees to accept the observation of the experimental project and sign the consent form. 4. High compliance, can cooperate to observe adverse events and efficacy.

Exclusion criteria

Exclusion criteria: 1. A mentally ill person; or a pregnant woman; 2. Patients with myocardial infarction or heart failure; 3. Patients with liver and kidney dysfunction; 4. Combined stroke patients; 5. Patients with arterial dissection or arterial embolization; 6. Patients who are allergic to Guhong injection.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy;

Secondary

MeasureTime frame
Echocardiography;Interleukin-6;C-reactive protein;Electrocardiogram;

Countries

China

Contacts

Public ContactChen Bojun

The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine (Guangdong Provincial Hospital of Traditional Chinese Medicine)

13902299108@163.com+86 13902299108

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026